(Q52237736)

27 April 2018

MDMA

0 references

title

Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

26 October 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

26 October 2022

author name string

M. D. Schechter

1

1 reference

PubMed ID

1676847

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1676847

26 October 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

27 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:009130579190010Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

https://api.elsevier.com/content/article/PII:009130579190010Y?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Pharmacology, Biochemistry and Behavior

26 October 2022

published in

1 reference

27 April 2018

volume

38

1 reference

27 April 2018

page(s)

539-544

1 reference

27 April 2018

issue

3

1 reference

27 April 2018

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Cocaine-induced place conditioning: importance of route of administration and other procedural variables.

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Drug discrimination studies with MDMA and amphetamine

26 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

26 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Measuring morphine's capacity to establish a place preference.

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

MDMA as a discriminative stimulus: isomeric comparisons.

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Functional consequences of fenfluramine neurotoxicity

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0091-3057(91)90010-Y

26 October 2022

Identifiers

1 reference

27 April 2018

PubMed ID

1676847

1 reference

27 April 2018